These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 38004497)
1. Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays. Cichero E; Francesconi V; Casini B; Casale M; Kanov E; Gerasimov AS; Sukhanov I; Savchenko A; Espinoza S; Gainetdinov RR; Tonelli M Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004497 [TBL] [Abstract][Full Text] [Related]
2. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice. Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling. Grossi G; Scarano N; Musumeci F; Tonelli M; Kanov E; Carbone A; Fossa P; Gainetdinov RR; Cichero E; Schenone S Molecules; 2024 Apr; 29(8):. PubMed ID: 38675561 [TBL] [Abstract][Full Text] [Related]
4. The anticonvulsant and proconvulsant effects of alpha2-adrenoreceptor agonists are mediated by distinct populations of alpha2A-adrenoreceptors. Szot P; Lester M; Laughlin ML; Palmiter RD; Liles LC; Weinshenker D Neuroscience; 2004; 126(3):795-803. PubMed ID: 15183527 [TBL] [Abstract][Full Text] [Related]
5. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1. Díaz-Holguín A; Saarinen M; Vo DD; Sturchio A; Branzell N; Cabeza de Vaca I; Hu H; Mitjavila-Domènech N; Lindqvist A; Baranczewski P; Millan MJ; Yang Y; Carlsson J; Svenningsson P Sci Adv; 2024 Aug; 10(32):eadn1524. PubMed ID: 39110804 [TBL] [Abstract][Full Text] [Related]
7. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640 [TBL] [Abstract][Full Text] [Related]
8. Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)- Krasavin M; Peshkov AA; Lukin A; Komarova K; Vinogradova L; Smirnova D; Kanov EV; Kuvarzin SR; Murtazina RZ; Efimova EV; Gureev M; Onokhin K; Zakharov K; Gainetdinov RR Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232878 [TBL] [Abstract][Full Text] [Related]
9. Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies. Tonelli M; Espinoza S; Gainetdinov RR; Cichero E Eur J Med Chem; 2017 Feb; 127():781-792. PubMed ID: 27823885 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1. Wainscott DB; Little SP; Yin T; Tu Y; Rocco VP; He JX; Nelson DL J Pharmacol Exp Ther; 2007 Jan; 320(1):475-85. PubMed ID: 17038507 [TBL] [Abstract][Full Text] [Related]
11. Discovery of potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach. Garisetti V; Dhanabalan AK; Dasararaju G Int J Biol Macromol; 2024 Apr; 264(Pt 2):130528. PubMed ID: 38431013 [TBL] [Abstract][Full Text] [Related]
12. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. Xie Z; Westmoreland SV; Bahn ME; Chen GL; Yang H; Vallender EJ; Yao WD; Madras BK; Miller GM J Pharmacol Exp Ther; 2007 Apr; 321(1):116-27. PubMed ID: 17234900 [TBL] [Abstract][Full Text] [Related]
14. Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Francesconi V; Cichero E; Kanov EV; Laurini E; Pricl S; Gainetdinov RR; Tonelli M Pharmaceuticals (Basel); 2020 Nov; 13(11):. PubMed ID: 33202687 [TBL] [Abstract][Full Text] [Related]
15. Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands. Scarano N; Espinoza S; Brullo C; Cichero E Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125796 [TBL] [Abstract][Full Text] [Related]
16. Trace amine-associated receptor 1 and drug abuse. Wu R; Liu J; Li JX Adv Pharmacol; 2022; 93():373-401. PubMed ID: 35341572 [TBL] [Abstract][Full Text] [Related]
17. TAAR1 as an emerging target for the treatment of psychiatric disorders. Liu J; Wu R; Li JX Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862 [TBL] [Abstract][Full Text] [Related]
18. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. Espinoza S; Ghisi V; Emanuele M; Leo D; Sukhanov I; Sotnikova TD; Chieregatti E; Gainetdinov RR Neuropharmacology; 2015 Jun; 93():308-13. PubMed ID: 25721394 [TBL] [Abstract][Full Text] [Related]
19. The Role of Biogenic Amine Transporters in Trace Amine-Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity. Miner NB; Phillips TJ; Janowsky A J Pharmacol Exp Ther; 2019 Oct; 371(1):36-44. PubMed ID: 31320495 [TBL] [Abstract][Full Text] [Related]